Akero Therapeutics (AKRO) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free AKRO Stock Alerts $19.92 -0.81 (-3.91%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Akero Therapeutics Short Interest DataCurrent Short Volume8,600,000 sharesPrevious Short Volume8,180,000 sharesChange Vs. Previous Month+5.13%Dollar Volume Sold Short$171.05 millionShort Interest Ratio / Days to Cover6.3Last Record DateApril 30, 2024Outstanding Shares69,151,000 sharesPercentage of Shares Shorted12.44%Today's Trading Volume457,600 sharesAverage Trading Volume1,137,890 sharesToday's Volume Vs. Average40% Short Selling Akero Therapeutics ? Sign up to receive the latest short interest report for Akero Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAKRO Short Interest Over TimeAKRO Days to Cover Over TimeAKRO Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Akero Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,600,000 shares $171.05 million +5.1%N/A6.3 $19.89 4/15/20248,180,000 shares $177.67 million +4.3%N/A6 $21.72 3/31/20247,840,000 shares $198.04 million -17.2%N/A5.8 $25.26 3/15/20249,470,000 shares $260.80 million +0.7%N/A6.9 $27.54 2/29/20249,400,000 shares $253.71 million +5.7%N/A6.9 $26.99 2/15/20248,890,000 shares $190.33 million +14.6%N/A8.2 $21.41 Get the Latest News and Ratings for AKRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,760,000 shares $167.69 million +2.1%N/A7.2 $21.61 1/15/20247,600,000 shares $170.54 million +3.1%N/A6.3 $22.44 12/31/20237,370,000 shares $172.09 million +12.4%N/A3.8 $23.35 12/15/20236,560,000 shares $150.29 million +3.0%N/A3.4 $22.91 11/30/20236,370,000 shares $106.63 million +3.6%N/A3.4 $16.74 11/15/20236,150,000 shares $90.10 million +4.4%N/A3.3 $14.65 10/31/20235,890,000 shares $70.21 million -3.6%N/A3.3 $11.92 10/15/20236,110,000 shares $89.39 million +5.7%N/A3.8 $14.63 9/30/20235,780,000 shares $292.35 million -3.5%N/A4.7 $50.58 9/15/20235,990,000 shares $312.92 million -5.4%N/A8.2 $52.24 8/31/20236,330,000 shares $314.16 million +8.0%N/A9.3 $49.63 8/15/20235,860,000 shares $278.17 million +1.7%N/A8.9 $47.47 7/31/20235,760,000 shares $249.98 million +5.1%N/A8.6 $43.40 7/15/20235,480,000 shares $249.72 million +14.4%N/A8 $45.57 6/30/20234,790,000 shares $223.65 million +6.2%N/A6.7 $46.69 6/15/20234,510,000 shares $249.00 million -3.8%N/A6.2 $55.21 5/31/20234,690,000 shares $209.08 million +0.9%N/A6.8 $44.58 5/15/20234,650,000 shares $221.85 million No ChangeN/A7 $47.71 4/30/20234,650,000 shares $208.04 million -2.7%N/A7.5 $44.74 4/15/20234,780,000 shares $181.59 million +8.1%N/A7.8 $37.99 3/31/20234,420,000 shares $169.11 million +30.8%N/A7.4 $38.26 3/15/20233,380,000 shares $136.92 million -0.9%N/A5.2 $40.51 2/28/20233,410,000 shares $155.19 million -5.0%N/A4.7 $45.51 2/15/20233,590,000 shares $161.55 million -5.8%N/A4.9 $45.00 1/31/20233,810,000 shares $188.60 million -8.9%N/A5 $49.50 1/15/20234,180,000 shares $210.00 million -20.5%N/A5.5 $50.24 12/30/20225,260,000 shares $288.25 million +27.7%N/A6.9 $54.80 12/15/20224,120,000 shares $181.57 million -16.8%N/A5.2 $44.07 11/30/20224,950,000 shares $230.18 million +21.6%N/A3.2 $46.50 11/15/20224,070,000 shares $182.25 million -12.5%N/A2.7 $44.78 10/31/20224,650,000 shares $196.51 million +17.1%13.5%3.2 $42.26 10/15/20223,970,000 shares $152.85 million -24.7%11.8%2.8 $38.50 9/30/20225,270,000 shares $179.44 million -3.7%17.1%3.8 $34.05 9/15/20225,470,000 shares $145.12 million -11.5%17.8%4.3 $26.53Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now AKRO Short Interest - Frequently Asked Questions What is Akero Therapeutics' current short interest? Short interest is the volume of Akero Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,600,000 shares of AKRO short. Learn More on Akero Therapeutics' current short interest. What is a good short interest ratio for Akero Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKRO shares currently have a short interest ratio of 6.0. Learn More on Akero Therapeutics's short interest ratio. Which institutional investors are shorting Akero Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akero Therapeutics: Walleye Trading LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Kingdon Capital Management L.L.C.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Akero Therapeutics' short interest increasing or decreasing? Akero Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,600,000 shares, an increase of 5.1% from the previous total of 8,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Akero Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Akero Therapeutics: ANI Pharmaceuticals, Inc. (1.10%), Morphic Holding, Inc. (12.82%), Kiniksa Pharmaceuticals, Ltd. (5.51%), Pacira BioSciences, Inc. (7.73%), Dynavax Technologies Co. (14.99%), Day One Biopharmaceuticals, Inc. (18.47%), Avadel Pharmaceuticals plc (4.99%), Gyre Therapeutics, Inc. (0.54%), Ligand Pharmaceuticals Incorporated (4.42%), Xencor, Inc. (10.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Akero Therapeutics stock? Short selling AKRO is an investing strategy that aims to generate trading profit from Akero Therapeutics as its price is falling. AKRO shares are trading down $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akero Therapeutics? A short squeeze for Akero Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKRO, which in turn drives the price of the stock up even further. How often is Akero Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKRO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ANIP Short Squeeze MORF Short Squeeze KNSA Short Squeeze PCRX Short Squeeze DVAX Short Squeeze DAWN Short Squeeze AVDL Short Squeeze GYRE Short Squeeze LGND Short Squeeze XNCR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKRO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders